Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5014157

NC(=NC(=O)c1nc(Cl)c(N)nc1N)NCCNC(=O)Nc1ccc(F)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 10/20 0.45
ALDH1A1 P00352 6/20 0.43
KDM4E B2RXH2 5/20 0.43
GLA P06280 5/20 0.43
HPGD P15428 5/20 0.43
HSD17B10 Q99714 5/20 0.43
SCNN1A P37088 4/20 0.43
GAA P10253 3/20 0.43
CYP1A2 P05177 3/20 0.43
LMNA P02545 2/20 0.43
CYP2D6 P10635 2/20 0.43
FTO Q9C0B1 2/20 0.43
BLM P54132 2/20 0.43
SLC22A1 O15245 1/20 0.43
HTR1A P08908 1/20 0.43
TSHR P16473 1/20 0.43
SLC9A1 P19634 1/20 0.43
MAOA P21397 1/20 0.43
ADORA2A P29274 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5014156 0.81 SCNN1A (0.40) ALDH1A1KDM4EGLAHPGDHSD17B10
Trifluoroacetic Acid SCHEMBL3527480 0.81 SCNN1A (0.46) PLAUALDH1A1KDM4EGLAHPGD
Trifluoroacetic Acid SCHEMBL5014166 0.79 PLAU (0.48) PLAUALDH1A1KDM4EGLAHPGD
Trifluoroacetic Acid SCHEMBL3524034 0.77 KCNH2 (0.47) PLAUALDH1A1KDM4EGLAHPGD
SCHEMBL3528728 0.76 PLAU (0.58) PLAUALDH1A1KDM4EGLAHPGD
SCHEMBL13165429 0.76 PLAU (0.58) PLAUALDH1A1KDM4EGLAHPGD
SCHEMBL13995413 0.75 CNR1 (0.44) ALDH1A1KDM4EGLAHPGDHSD17B10
SCHEMBL5014171 0.74 SCNN1A (0.52) PLAUALDH1A1KDM4EGLAHPGD
Phenamil SCHEMBL14504131 0.73 PLAU (0.58) PLAUALDH1A1KDM4EGLAHPGD
Phenamil SCHEMBL14973571 0.73 PLAU (0.58) PLAUALDH1A1KDM4EGLAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312212-A1 Organic Compounds NOVARTIS AG 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312212-A1 Organic Compounds TRPA1, TRPV1, TRPV3 PLAU 3355/4885ALDH1A1 1322/4885KDM4E 3755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.